MarketInOut Stock Screener Log In | Sign Up
 

Aytu BioPharma Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/12/2026 16:00
Aytu BioPharma Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization22.01 mln
Float9.96 mln
Earnings Date11/16/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.48
Reliable

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

0.51
Moderate leverage

Pre-Tax Margin

-25%
Deeply loss-making

ROE

-56.22
Deeply negative

Business Description

Aytu BioPharma is a Denver-based pharmaceutical company that develops and sells prescription medications across the United States and international markets. The company's primary focus is treating attention deficit hyperactivity disorder in children and adults through several branded drug products. It also offers a range of children's health products, including an allergy medicine and fluoride-based vitamins designed for infants and young children.

Key Fundamentals

EPS-1.16
ROE-56.22
RPS4.67
ROIC-11.00
ROA-12.11
Interest Cover-7.36
EBITDA, mln-8.41
EV / EBITDA-4.20
EV / EBIT-2.86
Revenue, mln57.57
EV / Revenue0.61

Quote Details

Last 1.97
Change -0.06 (-2.96%)
Open 1.99
Volume 23,246
Turnover 45,795
Average Volume 48,874

Financial Ratios

Pre-Tax Profit Margin-25
Leverage Ratio2.98
Current Ratio1.13
Price / Book0.70
Price / Cash Flow7.60
Price / Free Cash Flow14.28
Debt / Equity0.51
Price / Sales0.54

Financial Strength

Altman Z-Score-4.17
Piotroski F-Score 3 / 9
Beneish M-Score-3.48
Short Ratio7.10
Short % of Float3.69

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.43% 29 / 100   
1 Month -1.01% 55 / 100   
2 Months -12.44% 27 / 100   
6 Months -25.1% 19 / 100   
1 Year -21.51% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us